Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children - Paula Zapata-Cobo; Sara Salvador-Matín; Marta Velasco; Laura M. Palomino; Susana Clemente; Oscar Segarra; Ana Moreno-Álvarez; Ana Fernández-Lorenzo; Begoña Pérez-Moneo; Montse Montraveta; Cesar Sánchez; Mar Tolín; et al. (Elsevier, 2023)